These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 15777962

  • 1. Inhibition of tumor formation by snake venom disintegrin.
    Yang RS, Tang CH, Chuang WJ, Huang TH, Peng HC, Huang TF, Fu WM.
    Toxicon; 2005 Apr; 45(5):661-9. PubMed ID: 15777962
    [Abstract] [Full Text] [Related]

  • 2. Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells.
    Lee WJ, Chen WK, Wang CJ, Lin WL, Tseng TH.
    Toxicol Appl Pharmacol; 2008 Jan 15; 226(2):178-91. PubMed ID: 17961621
    [Abstract] [Full Text] [Related]

  • 3. Alendronate inhibits invasion of PC-3 prostate cancer cells by affecting the mevalonate pathway.
    Virtanen SS, Väänänen HK, Härkönen PL, Lakkakorpi PT.
    Cancer Res; 2002 May 01; 62(9):2708-14. PubMed ID: 11980672
    [Abstract] [Full Text] [Related]

  • 4. Treatment of bone metastasis induced by MDA-MB-231 breast cancer cells with an antibody against bone sialoprotein.
    Bäuerle T, Peterschmitt J, Hilbig H, Kiessling F, Armbruster FP, Berger MR.
    Int J Oncol; 2006 Mar 01; 28(3):573-83. PubMed ID: 16465361
    [Abstract] [Full Text] [Related]

  • 5. Tumor alphavbeta3 integrin is a therapeutic target for breast cancer bone metastases.
    Zhao Y, Bachelier R, Treilleux I, Pujuguet P, Peyruchaud O, Baron R, Clément-Lacroix P, Clézardin P.
    Cancer Res; 2007 Jun 15; 67(12):5821-30. PubMed ID: 17575150
    [Abstract] [Full Text] [Related]

  • 6. Inositol hexaphosphate (IP6) inhibits key events of cancer metastasis: I. In vitro studies of adhesion, migration and invasion of MDA-MB 231 human breast cancer cells.
    Tantivejkul K, Vucenik I, Shamsuddin AM.
    Anticancer Res; 2003 Jun 15; 23(5A):3671-9. PubMed ID: 14666663
    [Abstract] [Full Text] [Related]

  • 7. Type I collagen receptor (alpha 2 beta 1) signaling promotes the growth of human prostate cancer cells within the bone.
    Hall CL, Dai J, van Golen KL, Keller ET, Long MW.
    Cancer Res; 2006 Sep 01; 66(17):8648-54. PubMed ID: 16951179
    [Abstract] [Full Text] [Related]

  • 8. ALCAM, activated leukocyte cell adhesion molecule, influences the aggressive nature of breast cancer cells, a potential connection to bone metastasis.
    Davies S, Jiang WG.
    Anticancer Res; 2010 Apr 01; 30(4):1163-8. PubMed ID: 20530423
    [Abstract] [Full Text] [Related]

  • 9. The role of alpha2 beta1 and alpha3 beta1 integrin receptors in the initial anchoring of MDA-MB-231 human breast cancer cells to cortical bone matrix.
    Lundström A, Holmbom J, Lindqvist C, Nordström T.
    Biochem Biophys Res Commun; 1998 Sep 29; 250(3):735-40. PubMed ID: 9784415
    [Abstract] [Full Text] [Related]

  • 10. A monoclonal antibody directed against a human cell membrane antigen prevents cell substrate adhesion and tumor invasion.
    De Potter CR, Schelfhout AM, De Smet FH, Van Damme S, de Ridder L, Dhont E, van Emmelo J.
    Am J Pathol; 1994 Jan 29; 144(1):95-103. PubMed ID: 8291615
    [Abstract] [Full Text] [Related]

  • 11. The effect of versican G3 domain on local breast cancer invasiveness and bony metastasis.
    Yee AJ, Akens M, Yang BL, Finkelstein J, Zheng PS, Deng Z, Yang B.
    Breast Cancer Res; 2007 Jan 29; 9(4):R47. PubMed ID: 17662123
    [Abstract] [Full Text] [Related]

  • 12. Blocking αvβ3 integrin by a recombinant RGD disintegrin impairs VEGF signaling in endothelial cells.
    Montenegro CF, Salla-Pontes CL, Ribeiro JU, Machado AZ, Ramos RF, Figueiredo CC, Morandi V, Selistre-de-Araujo HS.
    Biochimie; 2012 Aug 29; 94(8):1812-20. PubMed ID: 22561350
    [Abstract] [Full Text] [Related]

  • 13. A conjugate of camptothecin and a somatostatin analog against prostate cancer cell invasion via a possible signaling pathway involving PI3K/Akt, alphaVbeta3/alphaVbeta5 and MMP-2/-9.
    Sun LC, Luo J, Mackey LV, Fuselier JA, Coy DH.
    Cancer Lett; 2007 Feb 08; 246(1-2):157-66. PubMed ID: 16644105
    [Abstract] [Full Text] [Related]

  • 14. Rhodostomin inhibits thrombin-enhanced adhesion of ROS 17/2.8 cells through the blockade of alphavbeta3 integrin.
    Yang RS, Chiang HS, Tang CH, Yeh CS, Huang TF.
    Toxicon; 2005 Sep 15; 46(4):387-93. PubMed ID: 16051297
    [Abstract] [Full Text] [Related]

  • 15. Modulation of bone microenvironment with zoledronate enhances the therapeutic effects of STI571 and paclitaxel against experimental bone metastasis of human prostate cancer.
    Kim SJ, Uehara H, Yazici S, He J, Langley RR, Mathew P, Fan D, Fidler IJ.
    Cancer Res; 2005 May 01; 65(9):3707-15. PubMed ID: 15867366
    [Abstract] [Full Text] [Related]

  • 16. Bone sialoprotein peptides are potent inhibitors of breast cancer cell adhesion to bone.
    van der Pluijm G, Vloedgraven HJ, Ivanov B, Robey FA, Grzesik WJ, Robey PG, Papapoulos SE, Lowik CW.
    Cancer Res; 1996 Apr 15; 56(8):1948-55. PubMed ID: 8620518
    [Abstract] [Full Text] [Related]

  • 17. Effects of Thomsen-Friedenreich antigen-specific peptide P-30 on beta-galactoside-mediated homotypic aggregation and adhesion to the endothelium of MDA-MB-435 human breast carcinoma cells.
    Glinsky VV, Huflejt ME, Glinsky GV, Deutscher SL, Quinn TP.
    Cancer Res; 2000 May 15; 60(10):2584-8. PubMed ID: 10825125
    [Abstract] [Full Text] [Related]

  • 18. Tanshinone I suppresses growth and invasion of human breast cancer cells, MDA-MB-231, through regulation of adhesion molecules.
    Nizamutdinova IT, Lee GW, Lee JS, Cho MK, Son KH, Jeon SJ, Kang SS, Kim YS, Lee JH, Seo HG, Chang KC, Kim HJ.
    Carcinogenesis; 2008 Oct 15; 29(10):1885-92. PubMed ID: 18586687
    [Abstract] [Full Text] [Related]

  • 19. Tranilast inhibits hormone refractory prostate cancer cell proliferation and suppresses transforming growth factor beta1-associated osteoblastic changes.
    Izumi K, Mizokami A, Li YQ, Narimoto K, Sugimoto K, Kadono Y, Kitagawa Y, Konaka H, Koh E, Keller ET, Namiki M.
    Prostate; 2009 Aug 01; 69(11):1222-34. PubMed ID: 19434660
    [Abstract] [Full Text] [Related]

  • 20. Silencing of transforming growth factor-beta1 in situ by RNA interference for breast cancer: implications for proliferation and migration in vitro and metastasis in vivo.
    Moore LD, Isayeva T, Siegal GP, Ponnazhagan S.
    Clin Cancer Res; 2008 Aug 01; 14(15):4961-70. PubMed ID: 18676771
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.